Evidence map›Paper›PMID 19414076›Full record

ArticleGastroenterology2009

More rare birds, and the occasional swan.

Brian R Edlin, Marla A Shu, Emily Winkelstein, Don C Des Jarlais, Michael P Busch, Barbara Rehermann, Thomas R O'Brien, Andrew H Talal, Leslie H Tobler, Marija Zeremski and 1 more

Abstract readCommentLetter
In one paragraph

Article in Gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Ethical and Practical Issues Associated With the Possibility of Using Controlled Human Infection Trials in Developing a Hepatitis C Virus Vaccine.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  4. Adaptive Immune Response against Hepatitis C Virus.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Challenges and Promise of a Hepatitis C Virus Vaccine.Cold Spring Harbor perspectives in medicine · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Brian R Edlin
Marla A Shu
Emily Winkelstein
Don C Des Jarlais
Michael P Busch
Barbara Rehermann
Thomas R O'Brien
Andrew H Talal
Leslie H Tobler
Marija Zeremski
Ann B Beeder

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024996 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2007 to 2011
$49.6M
VEGF VECTOR TO ISCHEMIC MYOCARDIUM W/DIFFUSE CORONARY DISEASEM01RR000047 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI DADHANIA, DARSHANA · 1985 to 2007
$36.4M
Risk Factors for HIV/AIDS in Drug UsersR01DA003574 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C, MCKNIGHT, COURTNEY · 1986 to 2025
$16.2M
Immunology of Acute and Chronic Viral Hepatitis in HumansZIADK054509 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI REHERMANN, BARBARA · 2009 to 2025
$15.1M
Role of the innate immune defenses in viral infectionsZIADK054516 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI REHERMANN, BARBARA · 2009 to 2023
$11.3M
Epidemiology of Oncogenic VirusesZIACP005782 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI O'BRIEN, THOMAS R · 2009 to 2025
$6.7M
HCV Transmission among Young IDUs in NYCR01DA021550 · NIDA · SUNY DOWNSTATE MEDICAL CENTER · PI EDLIN, BRIAN R. · 2008 to 2012
$4.1M
Acute HCV Infection in Injection Drug UsersR01DA016159 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI EDLIN, BRIAN R. · 2004 to 2008
$3.5M
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTIONR01DA009532 · NIDA · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI EDLIN, BRIAN R. · 1995 to 2004
$3.0M
CLINICAL AND HISTOLOGIC SPECTRUM OF HCV LIVER DISEASE INR01DA013245 · NIDA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI EDLIN, BRIAN R. · 1999 to 2001
$646k
HIV PREVALENCE AND INCIDENCE TRENDS AMONG IDUS 1986-1997R01DA012109 · NIDA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KRAL, ALEXANDER H · 1998 to 2000
$259k
CSAT SAMHSA HHS H79-TI12103Intramural NIH HHSNCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400NCI NIH HHS N02-CP-91027NCRR NIH HHS M01 RR000047NCRR NIH HHS M01-RR000047NCRR NIH HHS UL1 RR024996NCRR NIH HHS UL1-RR024996NIDA NIH HHS R01 DA003574NIDA NIH HHS R01 DA009532NIDA NIH HHS R01 DA012109NIDA NIH HHS R01 DA013245NIDA NIH HHS R01 DA016159NIDA NIH HHS R01 DA021550NIDA NIH HHS R01-DA021550NIDA NIH HHS R01-DA03574NIDA NIH HHS R01-DA09532NIDA NIH HHS R01-DA13245NIDA NIH HHS R01-DA16159
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Attitude to HealthAcute DiseaseAdolescentAdultCohort StudiesFemaleHepatitis CHIV InfectionsHIV SeropositivityHumansIncidenceIn Vitro TechniquesMaleNew York CityRisk AssessmentRisk-Taking

Identifiers

PMID19414076
PMCPMC3690554

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.